PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	56.56	73.82	65.24	28.84	12.16
Cash & Cash Equivalents	56.56	73.82	65.24	28.84	12.16
Cash Growth	-23.38%	13.15%	126.23%	137.13%	11628.38%
Other Current Assets	2.49	2.66	1.6	1.5	2.31
Total Current Assets	59.06	76.48	66.84	30.34	14.47
Property, Plant & Equipment	0.34	0.53	0.36	0.55	0.02
Total Long-Term Assets	0.34	0.53	0.36	0.55	0.02
Total Assets	59.39	77.01	67.2	30.89	14.49
Accounts Payable	6.98	1.22	1.31	1.42	1.2
Current Debt	4.22	0.29	0.26	0.12	0
Other Current Liabilities	2.42	8.31	2.19	1.74	1.6
Total Current Liabilities	13.63	9.82	3.76	3.27	2.79
Long-Term Debt	19.63	23.18	0.23	0.49	0
Total Long-Term Liabilities	19.63	23.18	0.23	0.49	0
Total Liabilities	33.26	33.01	3.99	3.76	2.79
Total Debt	23.85	23.47	0.49	0.61	0
Debt Growth	1.61%	4686.93%	-19.65%	-	-
Retained Earnings	-144.5	-101.56	-60.7	-43.79	-28.94
Shareholders' Equity	26.13	44	63.21	27.13	11.7
Net Cash / Debt	32.71	50.35	64.75	28.23	12.16
Net Cash / Debt Growth	-35.03%	-22.25%	129.38%	132.12%	16402.80%
Net Cash Per Share	1.06	1.76	2.53	1.69	2.50
Working Capital	45.43	66.66	63.08	27.07	11.68
Book Value Per Share	0.84	1.54	2.47	1.62	2.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).